Skip to main content
OpenTrials
Completed

NCT Number: NCT03550144

Improving Mental Health and Well-Being Via Awe Walks

Awe is a powerful positive emotion that offsets negative emotion and fosters prosocial behavior. This study examined the effects of awe on health and well-being in healthy older adults. Half of the participants took a weekly "awe walk" while the other half took a weekly walk with no further instructions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UCSF Memory and Aging Center

San Francisco, California, 94158, United States

About this study

Awe fosters well-being and positive emotions that promote social relationships. Awe shifts attention from ourselves to the outside world and is associated with diminished self-focused attention. We aimed to increase awe in healthy older adults to test whether greater awe experience would lead to gains in other types of positive emotional experience and reductions in negative emotional experience.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stable medical condition for 3 months prior to screening
  • Reliant informant with frequent contact with participant who is available to provide observations of participant
  • Fluent in English or Spanish
  • Age: 40 and above
  • Able to complete baseline assessments
  • Education or work history sufficient to exclude mental retardation
  • Physically acceptable for this study as confirmed by medical history, physical exam, neurological exam and clinical tests

Exclusion criteria

  • Major memory concerns/diagnosed memory condition
  • Korsakoff encephalopathy
  • Active substance abuse
  • Brain tumor
  • Active neoplastic disease (skin tumors other than melanoma are not exclusionary)
  • Parkinson's disease
  • Multiple sclerosis (untreated)
  • Sleep apnea
  • History of clinically significant stroke
  • Current evidence or history in the past 2 years of epilepsy, focal brain lesion, cancer, steroid use, or DSM-IV criteria for any major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse
  • Blindness, deafness, language difficulties or any other disability which may prevent the participant from participating or cooperating in the protocol

Treatment and study plan

Awe Walk

Behavioral

To examine the effect of weekly awe walks in cognitively healthy older adults.

Control Walk

Behavioral

To examine the effect of weekly walks in cognitively healthy older adults.

Primary outcomes

  1. Daily awe experience questionnaire

    Time frame: 8 weeks

    Increase in awe experience

Secondary outcomes

  1. Daily compassion experience questionnaire

    Time frame: 8 weeks

    Increase in daily compassion experience

  2. Daily negative emotional experience questionnaire

    Time frame: 8 weeks

    Decrease in daily negative emotional experience

  3. Generalized Anxiety Disorder- 7 Item Scale

    Time frame: 8 weeks

    Decrease in anxiety

  4. Satisfaction With Life Scale

    Time frame: 8 weeks

    Increase in well-being

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • University of California, Berkeley

Registry information

Official study title

Effects of Awe on Mental Health and Well-Being

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Jun 8, 2018
Registry last updated
Mar 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.